Ophthalmic Devices - Eastern Europe

  • Eastern Europe
  • The Ophthalmic Devices market market in Eastern Europe is predicted to achieve a revenue of US$0.62bn by the year 2024.
  • It is expected that the revenue will display an annual growth rate (CAGR 2024-2029) of 4.70%, ultimately leading to a market volume of US$0.78bn by 2029.
  • When compared globally, the United States is projected to generate the highest revenue of US$14,000.00m in 2024.
  • In Eastern Europe, the ophthalmic devices market is experiencing a surge in demand due to the increasing prevalence of age-related eye diseases.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Eastern Europe is experiencing significant growth due to several factors such as increasing prevalence of eye diseases, rising geriatric population, and advancements in technology. Customer preferences in the Ophthalmic Devices market in Eastern Europe are influenced by factors such as quality, affordability, and accessibility of products. Customers in this region prioritize products that offer high quality and precision in diagnosing and treating eye conditions. Affordability is also a key consideration for customers, as they seek cost-effective solutions for their eye health needs. Additionally, customers value accessibility to ophthalmic devices, especially in remote areas where access to healthcare facilities may be limited. Trends in the Ophthalmic Devices market in Eastern Europe include the growing adoption of advanced technologies such as optical coherence tomography (OCT) and femtosecond lasers. These technologies offer improved accuracy and precision in diagnosing and treating various eye conditions, leading to better patient outcomes. The market is also witnessing an increasing demand for contact lenses and eyeglasses, driven by the rising prevalence of refractive errors and the growing popularity of cosmetic contact lenses. Local special circumstances in Eastern Europe, such as the presence of a large geriatric population, contribute to the growth of the Ophthalmic Devices market. With aging, the risk of developing age-related eye diseases such as cataracts and age-related macular degeneration increases, leading to a higher demand for ophthalmic devices. Additionally, the region's healthcare infrastructure and government initiatives play a crucial role in promoting the adoption of ophthalmic devices and ensuring their availability to a wider population. Underlying macroeconomic factors, such as the overall economic growth in Eastern Europe, also contribute to the development of the Ophthalmic Devices market. As the region's economies continue to grow, there is an increase in disposable income and healthcare expenditure, which in turn drives the demand for ophthalmic devices. Moreover, favorable reimbursement policies and the presence of key market players in the region further propel market growth. In conclusion, the Ophthalmic Devices market in Eastern Europe is witnessing significant growth driven by customer preferences for quality, affordability, and accessibility of products. The market is characterized by the adoption of advanced technologies, increasing demand for contact lenses and eyeglasses, and the presence of a large geriatric population. Underlying macroeconomic factors such as economic growth and favorable reimbursement policies also contribute to the market's development.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)